Cargando…

Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection

BACKGROUND: To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Index (phi), and phi density (PHID) as independent biomarkers and in composition of multivariable models in predicting high-grade prostatic intraepithelial neoplasia (HGPIN) and overall and clinically si...

Descripción completa

Detalles Bibliográficos
Autores principales: Barisiene, Marija, Bakavicius, Arnas, Stanciute, Diana, Jurkeviciene, Jolita, Zelvys, Arunas, Ulys, Albertas, Vitkus, Dalius, Jankevicius, Feliksas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396080/
https://www.ncbi.nlm.nih.gov/pubmed/32775459
http://dx.doi.org/10.1155/2020/9872146
_version_ 1783565516960432128
author Barisiene, Marija
Bakavicius, Arnas
Stanciute, Diana
Jurkeviciene, Jolita
Zelvys, Arunas
Ulys, Albertas
Vitkus, Dalius
Jankevicius, Feliksas
author_facet Barisiene, Marija
Bakavicius, Arnas
Stanciute, Diana
Jurkeviciene, Jolita
Zelvys, Arunas
Ulys, Albertas
Vitkus, Dalius
Jankevicius, Feliksas
author_sort Barisiene, Marija
collection PubMed
description BACKGROUND: To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Index (phi), and phi density (PHID) as independent biomarkers and in composition of multivariable models in predicting high-grade prostatic intraepithelial neoplasia (HGPIN) and overall and clinically significant prostate cancer (PCa). METHODS: 210 males scheduled for prostate biopsy with total PSA (tPSA) range 2-10 ng/mL and normal digital rectal examination were enrolled in the prospective study. Blood samples to measure tPSA, free PSA (fPSA), and p2PSA were collected immediately before 12-core prostate biopsy. Clinically significant PCa definition was based on Epstein's criteria or ISUP grade ≥ 2 at biopsy. RESULTS: PCa has been diagnosed in 112 (53.3%) patients. Epstein significant and ISUP grade ≥ 2 PCa have been identified in 81 (72.3%) and 40 (35.7%) patients, respectively. Isolated HGPIN at biopsy have been identified in 24 (11.4%) patients. Higher p2PSA and its derivative mean values were associated with PCa. At 90% sensitivity, PHID with cut-off value of 0.54 have demonstrated the highest sensitivity of 35.7% for overall PCa detection, so PHID and phi with cut-off values of 33.2 and 0.63 have demonstrated the specificity of 34.7% and 34.1% for ISUP grade ≥ 2 PCa detection at biopsy, respectively. In univariate ROC analysis, PHID with AUC of 0.77 and 0.80 was the most accurate predictor of overall and Epstein significant PCa, respectively, so phi with AUC of 0.77 was the most accurate predictor of ISUP grade ≥ 2 PCa at biopsy. In multivariate logistic regression analysis, phi improved diagnostic accuracy of multivariable models by 5% in predicting ISUP grade ≥ 2 PCa. CONCLUSIONS: PHID and phi have shown the greatest specificity at 90% sensitivity in predicting overall and clinically significant PCa and would lead to significantly avoid unnecessary biopsies. PHID is the most accurate predictor of overall and Epstein significant PCa, so phi is the most accurate predictor of ISUP grade ≥ 2 PCa. phi significantly improves the diagnostic accuracy of multivariable models in predicting ISUP grade ≥ 2 PCa.
format Online
Article
Text
id pubmed-7396080
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73960802020-08-07 Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection Barisiene, Marija Bakavicius, Arnas Stanciute, Diana Jurkeviciene, Jolita Zelvys, Arunas Ulys, Albertas Vitkus, Dalius Jankevicius, Feliksas Biomed Res Int Research Article BACKGROUND: To evaluate the diagnostic potential of [-2] proPSA (p2PSA), %p2PSA, Prostate Health Index (phi), and phi density (PHID) as independent biomarkers and in composition of multivariable models in predicting high-grade prostatic intraepithelial neoplasia (HGPIN) and overall and clinically significant prostate cancer (PCa). METHODS: 210 males scheduled for prostate biopsy with total PSA (tPSA) range 2-10 ng/mL and normal digital rectal examination were enrolled in the prospective study. Blood samples to measure tPSA, free PSA (fPSA), and p2PSA were collected immediately before 12-core prostate biopsy. Clinically significant PCa definition was based on Epstein's criteria or ISUP grade ≥ 2 at biopsy. RESULTS: PCa has been diagnosed in 112 (53.3%) patients. Epstein significant and ISUP grade ≥ 2 PCa have been identified in 81 (72.3%) and 40 (35.7%) patients, respectively. Isolated HGPIN at biopsy have been identified in 24 (11.4%) patients. Higher p2PSA and its derivative mean values were associated with PCa. At 90% sensitivity, PHID with cut-off value of 0.54 have demonstrated the highest sensitivity of 35.7% for overall PCa detection, so PHID and phi with cut-off values of 33.2 and 0.63 have demonstrated the specificity of 34.7% and 34.1% for ISUP grade ≥ 2 PCa detection at biopsy, respectively. In univariate ROC analysis, PHID with AUC of 0.77 and 0.80 was the most accurate predictor of overall and Epstein significant PCa, respectively, so phi with AUC of 0.77 was the most accurate predictor of ISUP grade ≥ 2 PCa at biopsy. In multivariate logistic regression analysis, phi improved diagnostic accuracy of multivariable models by 5% in predicting ISUP grade ≥ 2 PCa. CONCLUSIONS: PHID and phi have shown the greatest specificity at 90% sensitivity in predicting overall and clinically significant PCa and would lead to significantly avoid unnecessary biopsies. PHID is the most accurate predictor of overall and Epstein significant PCa, so phi is the most accurate predictor of ISUP grade ≥ 2 PCa. phi significantly improves the diagnostic accuracy of multivariable models in predicting ISUP grade ≥ 2 PCa. Hindawi 2020-07-21 /pmc/articles/PMC7396080/ /pubmed/32775459 http://dx.doi.org/10.1155/2020/9872146 Text en Copyright © 2020 Marija Barisiene et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Barisiene, Marija
Bakavicius, Arnas
Stanciute, Diana
Jurkeviciene, Jolita
Zelvys, Arunas
Ulys, Albertas
Vitkus, Dalius
Jankevicius, Feliksas
Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
title Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
title_full Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
title_fullStr Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
title_full_unstemmed Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
title_short Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
title_sort prostate health index and prostate health index density as diagnostic tools for improved prostate cancer detection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396080/
https://www.ncbi.nlm.nih.gov/pubmed/32775459
http://dx.doi.org/10.1155/2020/9872146
work_keys_str_mv AT barisienemarija prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT bakaviciusarnas prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT stanciutediana prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT jurkevicienejolita prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT zelvysarunas prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT ulysalbertas prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT vitkusdalius prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection
AT jankeviciusfeliksas prostatehealthindexandprostatehealthindexdensityasdiagnostictoolsforimprovedprostatecancerdetection